SNP | Â | Total (n) | Genotype | Allele | Author |
---|---|---|---|---|---|
P2Y1 c.1622A > G |  | AA/AG/GG | A/G | ||
 | Present study | 194 | 106 (54.6%)/68 (35.1%)/20 (10.3%) | 280 (72.2%)/108 (27.8%) | Present |
 | Korea | 415 | 71 (44.9%)/76 (48.1%)/11 (7.0%)* | 218 (69.0%)/98 (31.0%) | Kim et al. [7] |
 | Hunan Province of China | 323 | 155 (48.0%)/138 (42.7%)/30 (9.3%) | 448 (69.3%)/198 (30.7%) | Li et al. [20] |
P2Y12 i-744 T > C |  |  | TT/TC/CC | T/C |  |
 | Present study | 194 | 163 (84.0%)/28 (14.4%)/3 (1.5%) | 354 (91.2%)/34 (8.8%) | Present |
 | South India | 221 | 185 (83.7%)/35 (15.8%)/1 (0.5%) | 405 (91.6%)/37 (8.4%) | Priyadharsini et al. [1] |
 | Western India | 102 | 87 (85.2%)/12 (11.8%)/3 (2.9%) | 186 (91.2)/18 (8.8%) | Shalia et al. [21] |
 | Egypt | 40 | 39 (97.5%)/1 (2.5%)/0 (0%)* | 79 (98.8%)/1 (1.2%)* | Zoheir et al. [8] |
 | Iran | 112 | 1 (0.9%)/8 (7.1%)/103 (92.0%)* | 10 (4.5%)/214 (95.5%)* | Azarpira et al. [23] |
 | Korea | 415 | 283 (68.2%)/125 (30.1%)/7 (1.7%)* | 691 (83.3%)/139 (16.7%)* | Kim et al. 2013 [7] |
P2Y12 c.34C > T |  |  | CC/CT/TT | C/T |  |
 | Present study | 194 | 124 (63.9%)/60 (30.9%)/10 (5.2%) | 308 (79.4%)/80 (20.6%) | Present |
 | Korea | 415 | 83 (52.5%)/66 (41.8%)/9 (5.7%) | 232 (73.4%)/84 (26.6%) | Kim et al. 2013 [7] |